A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis

NCT07436234 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: AK139
DRUG: AK139
DRUG: Placebo

Sponsor

Akeso